Skip to main content
Livermore
Livermore
ZHEN

Protalix BioTherapeutics, Inc.

PLX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001006281

No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Protalix BioTherapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of PLX: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders63630
Shares8.19M11.9M+3.72M (+45.5%)
Value$21.0M$17.6M−$3.33M (−15.9%)

New holders (30)

Institutions that held Protalix BioTherapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to PLX in Q2 2025
InstitutionSharesValue% of portfolio
Geode Capital Management, LLC826,333$1.22M0.00%
Vanguard Group Inc484,798$717.5K0.00%
State Street Corp444,239$657.5K0.00%
Charles Schwab Investment Management Inc175,070$259.1K0.00%
Evergreen Capital Management LLC171,338$253.6K0.01%
Diametric Capital, LP143,272$212.0K0.11%
Bank of New York Mellon Corp134,287$198.7K0.00%
Nuveen, LLC90,188$133.5K0.00%
Rhumbline Advisers69,796$103.3K0.00%
New York State Common Retirement Fund69,000$102.1K0.00%
Prelude Capital Management, LLC56,055$83.0K0.01%
Dimensional Fund Advisors LP45,571$67.7K0.00%
Invesco Ltd.45,141$66.8K0.00%
Mirae Asset Global ETFs Holdings Ltd.38,075$56.4K0.00%
Intech Investment Management LLC36,490$54.0K0.00%
Wells Fargo & Company36,034$53.3K0.00%
Price T Rowe Associates Inc35,278$53.0K0.00%
Harel Insurance Investments & Financial Services Ltd.26,000$40.0K0.00%
Wolverine Trading, LLC24,508$37.7K0.00%
Police & Firemen's Retirement System of New Jersey18,554$27.5K0.00%
Cascade Financial Partners, LLC17,000$25.2K0.00%
ProShare Advisors LLC14,297$21.2K0.00%
Alliancebernstein L.P.11,720$17.3K0.00%
Legal & General Group Plc7,757$11.5K0.00%
Ameritas Investment Partners, Inc.7,119$10.5K0.00%
California State Teachers Retirement System4,350$6.44K0.00%
Amalgamated Bank2,381$4.00K0.00%
Sterling Capital Management LLC168$2490.00%
Tower Research Capital LLC (TRC)127$1880.00%
Royal Bank of Canada293$00.00%

Sold out (30)

Institutions that held Protalix BioTherapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of PLX in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Millennium Management LLC963,011$2.47M
Marshall Wace, LLP615,085$1.57M
Jane Street Group, LLC294,318$753.5K
Gsa Capital Partners LLP209,292$536.0K
Omers Administration Corp179,300$459.0K
Schonfeld Strategic Advisors LLC163,058$417.4K
Squarepoint Ops LLC120,786$309.2K
Qube Research & Technologies Ltd118,808$304.1K
Jain Global LLC81,963$209.8K
Balyasny Asset Management LLC76,063$194.7K
Point72 Asia (Singapore) Pte. Ltd.54,174$138.7K
Cubist Systematic Strategies, LLC53,380$136.7K
Quantessence Capital LLC51,243$131.2K
LMR Partners LLP49,025$125.5K
Kestra Advisory Services, LLC44,500$113.9K
Prudential Financial Inc36,400$93.2K
Two Sigma Advisers, LP33,015$84.5K
Creative Planning32,740$83.8K
Catalyst Funds Management Pty Ltd27,139$69.5K
HSBC Holdings PLC25,535$64.3K
Capula Management Ltd15,690$40.2K
Capstone Investment Advisors, LLC15,336$39.3K
Raymond James Financial Inc15,174$38.8K
GWM Advisors LLC15,080$38.6K
Brevan Howard Capital Management LP13,474$34.5K
Hudson Bay Capital Management LP12,000$30.7K
Acadian Asset Management LLC9,691$24.0K
Point72 (DIFC) Ltd5,623$14.4K
Citadel Advisors LLC2,818$7.21K
Lazard Asset Management LLC797$2.00K